PsychPlus Brownsville Clinic - Psychiatrist and Therapist
525 Villa Maria Boulevard, Brownsville
4.6(38 Google reviews)
United States
1 listed treatment center serving Brownsville and the surrounding area.
525 Villa Maria Boulevard, Brownsville
4.6(38 Google reviews)
For people in Brownsville, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and how services are billed. Both the medication and the visit for supervised administration and monitoring may generate charges. Ask for an explanation of all expected charges rather than a medication-only estimate.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medicines you took, how long you took them, and your response. Ask the treatment center who submits these records, whether anything is missing, and how you will learn the insurer’s decision. Authorization does not necessarily mean every charge is covered.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Texas Medicaid coverage also depends on the plan and setting. The Brownsville center currently listed in this directory is marked as not accepting Medicare or Medicaid; confirm directly before arranging care. That listing does not establish whether your benefits could cover treatment elsewhere.
Manufacturer savings programs exist for eligible commercially insured patients, not patients using government insurance. Eligibility and terms apply, so ask about current requirements without assuming you qualify.
Before starting, ask the center and insurer:
SPRAVATO® treatment requires in-person visits at a healthcare setting certified through the Spravato REMS program. You self-administer the nasal spray under direct observation of a healthcare provider; it is never sent home. Brownsville has one listed center offering Spravato, but its REMS certification status is not recorded in this directory. Confirm certification and appointment availability directly before making plans.
For treatment-resistant depression, the typical labeled schedule begins with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may then be weekly or every two weeks. Your prescriber individualizes the schedule; do not assume a fixed frequency before your evaluation.
Set aside at least two hours after each dose for monitoring, plus time for check-in, preparation, and discharge. Monitoring may need to continue longer. Discuss recurring appointment blocks or time off with your employer, and arrange help with caregiving or other responsibilities as needed.
A driver is required for the trip home. You must not drive or operate machinery until the next day after a restful sleep. Arrange a dependable ride for every appointment and a backup option. Ask the center about its discharge requirements before relying on a hired ride.
If no Brownsville center is listed when you search, or the listed option is unavailable, ask your clinician about alternatives. This directory also lists centers in Austin, Houston, San Antonio, Friendswood, Dallas, Fort Worth, McKinney, and El Paso. These are statewide alternatives, not necessarily practical commutes. Confirm certification, availability, and transportation feasibility before committing to repeated visits.
This directory lists one Brownsville center as offering SPRAVATO®, but its REMS certification status is not recorded. Ask the center to confirm current certification, whether it is accepting new patients, and how it evaluates referrals. A directory listing alone is not proof of certification. Spravato must be administered in a REMS-certified healthcare setting, never at home.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal thoughts or behavior, together with an oral antidepressant. It is not approved for children. A clinician must assess your diagnosis, treatment history, and health risks to determine whether it is appropriate.
Coverage depends on your plan, treatment setting, and authorization requirements. Insurers commonly request documentation of earlier antidepressant trials. Ask about coverage for both the medication and monitored visit. The listed Brownsville center is marked as not accepting Medicare or Medicaid, so confirm directly. That does not mean those programs never cover treatment; benefits and provider participation are separate questions.
You administer the nasal spray yourself under a healthcare provider’s direct observation. After each dose, the team monitors you for at least two hours, including checks for sedation, dissociation, breathing problems, and blood pressure increases. Allow additional time for other appointment steps. Arrange someone else to take you home, and do not drive until the next day after a restful sleep.
Important risks include sedation, dissociation—a feeling of disconnection from yourself or your surroundings—respiratory depression, and increased blood pressure. Spravato also has boxed warnings about abuse and misuse and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Share your medical history, medicines, and substance-use history with the clinician, and ask how the team responds to symptoms during monitoring.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Do not wait for a treatment consultation if you are in crisis. Call or text 988 for immediate crisis support, or call 911 in an emergency. Tell your treating clinician promptly about new or worsening suicidal thoughts.
Approved uses, nearby treatment centers, and medically sourced patient guides.